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Abstract
Injection nerve palsy (INP) in the median nerve is an iatrogenic peripheral nerve injury that
can be inflicted by a faulty intramuscular injection in the median nerve area. The literature
reports a 2% incidence of INP among all peripheral nerve injuries. The incidence of INP in
developed countries has decreased significantly during the past decade, but the injury appears
to remain prevalent in developing countries. A deep understanding of the anatomy of the
peripheral nerves, and a precise intramuscular injection technique, have been shown to be vital
for preventing INP in the median nerve. Debates continue regarding what, if any, intervention
is necessary for injection palsies; and if it is needed, when it should be carried out. In this
article, we will review the literature related to median injection nerve palsy and recommended
methods of prevention.
Categories: Neurology, Pain Management, Neurosurgery
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Introduction And Background
Injection nerve palsy (INP) is an iatrogenic peripheral nerve injury with a reported incidence of
2% among all peripheral nerve injuries recorded (Figures 1-2) [1-2]. The peripheral nerve
consists of a variable number of fascicles bound by a loose connective tissue known as the
epineurium [3]. Each fascicle is surrounded by the multi-layered perineurium, inside which
nerve fibers are packed in a tight bundle [3]. The endoneurium, a thin sheath of connective
tissue, surrounds each individual nerve fiber [3]. Under normal conditions, the perineurium
acts as a barrier to diffusion (e.g., the blood-nerve barrier) [4-5]. It cooperates with the
endothelium of the endoneurial blood vessels to maintain this barrier, which regulates the
intrafascicular milieu of the nerve [4-5].
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FIGURE 1: A left-sided hematoma (arrow) in the median nerve
within the cubital fossa
FIGURE 2: A subcutaneous hematoma following intravenous
access. This same specimen was found to have a transection
of a branch of the superficial radial nerve as it crossed the
anatomical snuffbox
Kalichman, et al. noted axonal and myelin degeneration following the injection of a neurotoxic
agent, with a dense concentration of inflammatory cells at the site of nervous injury [6].
Kalichman, et al. speculated that these morphologies indicate nerve injury [6]. Additionally,
they emphasized their observation of significant endoneurial edema [6]. In light and electron
microscopic studies, edema is characterized as a structureless space in the endoneurium. Under
normal conditions, fluid is restricted to the subperineurial region. However, in reported cases
of nerve injury, it is present in the perineurial spaces and all parts of the endoneurial
compartment of the injured nerves [6].   
Kakati, et al. reported that the onset of symptoms following INP was immediate in 90% of
cases, although most patients were not referred until long after their injury [7]. In most
cases, patients developed severe pain along the distribution of the affected nerve in
addition to paresthesias [7]. The immediate onset of various degrees of motor and sensory
deficit was also reported [7]. Motor deficits are generally more severe, while sensory
deficits are commonly associated with severe pain, paresthesia, or causalgia along the
distribution of the affected nerve [7-8]. The immediate symptoms are most likely to result
from the direct effect of injection within a nerve [7-9]. Kakati, et al. suggested perineural
fibrosis as a probable cause of the delayed worsening of INP [7].
The anatomical proximity of a nerve to the injection site is the factor that most critically
determines the degree of injury [7-8]. The nature and quantity of the injected substance are
additional factors thought to contribute to the severity of injury, though to a significantly lesser
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extent [8]. The drugs reported to be among the most neurologically toxic are: penicillin,
diazepam, chlorpromazine, mependine, dimenhydrinate, tetanus toxoid, procaine, and
hydrocortisone. The size of the nerve is also thought to correspond to its vulnerability to injury.
This explains the high incidence of INP in the large sciatic nerve [7]. Injury to the sciatic nerve
has been reported to account for 84.3% of all INP cases, followed by injury to the radial nerve at
5.4% [7].
Western studies have reported a higher incidence of INP in the geriatric population while
studies in Southern Asia have revealed a higher incidence in the pediatric population [7, 10-11].
The incidence of INP in developed countries has decreased significantly over the past decade,
but the injury appears to remain prevalent in developing countries. Intramuscular injections
are often used to treat common illnesses such as fever and infections [10]. Pandian, et al.
reported that 86% of injection palsies in North India resulted from improper administration of
intramuscular injections by an uncertified medical practitioner [2]. Kotwal, et al. estimated that
around half of the injections performed in developing countries are unsafe [12].
In the following section, we will describe injection nerve palsies with regards to the median
nerve in more detail.
Review
Median nerve injection palsy
Median nerve palsy accounts for 3.6% all reported cases of INP [7]. The median cubital vein,
located close to the median nerve, is most commonly used to draw blood and administer IV
fluids. It is most commonly caused by inaccurate injections of local anesthetics [8].
In 1990, Linskey and Segal published a case study on a diagnosis of median nerve injection
palsy [9]. The injury occurred in a 24-year-old male diagnosed with a left carpal tunnel
syndrome. He was injected with 1 ml of methylprednisolone suspended in polyethylene glycol
and mixed with 0.5% bupivacaine hydrochloride. The intention was to direct the injection into
the patient’s left carpal tunnel. During the injection, the patient experienced “a new type of
pain” (i.e., not associated with carpal tunnel syndrome) shooting down his hand into his first
two fingers. The symptoms did not diminish after the injection had been completed. The
patient was later referred to a neurosurgery clinic where exposure of his left median nerve by
sectioning the transverse carpal ligament revealed the presence of an opaque white foreign
material within the epineurium. The patient also underwent an epineurectomy, during which a
similar white precipitate was observed within several nerve fascicles. Such thickening was
previously reported by Posch and Marcotte, who presented an intraoperative picture of a white
plaque within the thickened median nerve epineurium [13]. They referred to the plaque as a
“median nerve granuloma” [14].
While motor function is more severely affected than sensory function in most cases, the
opposite was true for the patient in Linskey and Segal’s case study [9]. This was proposed to
reflect the primarily sensory function of the distal median nerve and to indicate that only some
nerve fascicles had been affected [9]. Consequently, a spontaneous recovery is highly likely,
although a residual deficit would generally remain [9].
Among the substances injected, methylprednisolone has been reported as intermediately toxic
[15]. Curtiss and Tucker reported bupivacaine as one of the least toxic local anesthetics, yet
claimed that it can nevertheless cause significant axonal degeneration [16]. Chino, et al. and
Combes and Clark provided evidence of the neurotoxicity of the polyethylene glycol in which
the methylprednisolone was suspended [17]. Linskey and Segal compared their observations
with past studies in which the steroid was the sole injected substance in order to determine the
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main cause of the patient’s injection palsy [9, 16]. Since a similar white plaque was present in
these cases, it was deduced that methylprednisolone was the toxin responsible for the patient’s
neurological impairments [9].
Another case of median nerve injection palsy was reported by Fremling and Mackinnon in 1996
[8]. The patient was a 68-year-old female who developed an abscess on the medial aspect of her
mid-upper left arm following a cat scratch. An incision intended to drain the abscess was
performed by her family physician. The skin was initially anesthetized with 1% lidocaine and
persistent discomfort was experienced following the injection. During a second injection, the
patient complained that she had lost sensation in her thumb, index, and long fingers, and that
she was no longer able to flex her thumb and index finger. The patient later failed to regain her
sensory and motor functions along the distribution of her left median nerve [8]. Two days after
the incident, surgical exploration revealed that the median nerve was intact. Despite the
absence of overt indications of nerve injury, the patient continued to experience severe pains.
A series of medications including amitriptyline, clonidine, and desipramine were prescribed
over the following six months. Nevertheless, her pain remained severe. Nerve conduction
studies around five months after the cat scratch indicated a severe median nerve injury. There
was no response for median sensory palmar latency, although normal distal motor latency was
retained. After seven months, the patient experienced severe hyperalgesia. Her evaluation
revealed the loss of functional sensory and motor function along the distribution of her left
median nerve [8]. On the basis of her experience of severe chronic pain, a surgical procedure
with nerve grafting was performed. The patient noted no change in her motor function
postoperatively. During a follow-up 18 months post-surgery, only partial relief of pain was
reported [8].
Clinical relevance/application
A deep understanding of the anatomy of the peripheral nerves, and a precise intramuscular
injection technique, have been shown to be vital for preventing injection nerve palsy. Severe
radiating pain should indicate an injection directed inside a nerve [8-9]. It is critical the patient
experiencing such pain should immediately notify their provider and the injection immediately
stopped. Additional precautions should also be taken since more potentially neurotoxic agents
are involved. A heightened risk for injection palsy is often associated with patients who are
heavily sedated (i.e., under regional or general anesthesia), as they are unable to notify their
providers of uncommon symptoms, such as extraordinary pain during injection [8-9].
The experimental work by Kalichman, et al. established previously unreported clinical facts
regarding injection-induced nerve palsy [6]. They noted the neurotoxicity of a wide spectrum of
lipophilic anesthetics, rather than just a few specific agents. Furthermore, while it had
traditionally been believed that only intraneural injections can inflict significant nerve injury,
Kalichman et al. discovered that substantial injury can be induced by the extraneural injection
of local anesthetics [6]. This finding further supported the hypothesis that the endoneurial
blood-nerve barrier is disrupted by neurotoxic agents in the perineurial sheath. It was proposed
that alteration in permeability allows an injected neurotoxic agent to affect the nerve directly
[10].  
For steroids, Linskey and Segal suggested an ulnar injection to the palmaris longus tendon [9].
If no palmaris longus is present, the injection should be made in line with the fourth digit [9]. It
is important to pay close attention when positioning the needle tip [9]. It is advised the needle
tip should lie beneath the transverse carpal ligament but outside the median nerve epineurium
[9]. The importance of a patient’s subjective response during the procedure cannot be stressed
enough. The injection is to be stopped immediately if there is any indication of pain or
paresthesia [7-9]. Debates continue regarding what, if any, intervention is necessary for
injection palsies; and, if it is needed, when it should be carried out. Kakati, et al. suggest that
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surgical treatments can help if performed within a reasonable period following the injury [7].  A
three to six-month observation period is recommended to determine whether there is
spontaneous recovery [9]. This can then be used to decide whether further intervention is
necessary [9].
Conclusions
Complications following intravenous and intramuscular injections are relatively low; however,
nerve injury after such procedures can occur. Therefore, the clinician should be aware of this
possibility and have a heightened sense of the regional anatomy around the target injection
site. In this paper, we introduced the topic of injection nerve palsy and reviewed the literature
regarding the incidence rate of symptoms and possible treatments. Nerve palsy due to injection
is a serious complication due to the reported symptoms, and an open "error culture" instead of
a "blame culture" must be promoted.
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